Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
885
datasets available to search
ShareScore release 0.9.0
Dataset results
885 results for “cyclophosphamide”
Pharmaco-immunological Study of Interferon-alpha and Metronomic Cyclophosphamide Association in Neuroendocrine Tumors
ClinicalTrials.gov study NCT02838342. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluation of the Immunological Effects of a Combined Treatment With Radiation and Cyclophosphamide in Metastasized Breast Cancer Patients
ClinicalTrials.gov study NCT02441270. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Thiotepa, Cyclophosphamide, Clarithromycin and Cytarabine
ClinicalTrials.gov study NCT06060782. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Autologous Transplant Using Dose-Escalated Total Body Irradiation & Cyclophosphamide & Palifermin for NHL
ClinicalTrials.gov study NCT03042585. IPD Sharing: NO. Countries: 1. Publications: 0.
Fludarabine, Cyclophosphamide, and Thalidomide in Treating Patients With Angioimmunoblastic T-Cell Lymphoma
ClinicalTrials.gov study NCT00958854. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Induction Therapy With Anti-TNFα vs Cyclophosphamide in Severe Behçet Disease
ClinicalTrials.gov study NCT03371095. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
High-dose Chemotherapy with Thiotepa, Busulfan, and Cyclophosphamide Followed by Autologous Stem Cell Transplantation in Central Nervous System Lymphoma
ClinicalTrials.gov study NCT06625359. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Azacitidine With Rituximab, Vincristine, and Cyclophosphamide in Refractory Lymphoma
ClinicalTrials.gov study NCT00901069. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Trial Exploring Feasibility of Densification and Optimal Sequencing of Postoperative Adjuvant Fluorouracil, Epirubicin Plus Cyclophosphamide (FEC) and Docetaxel Chemotherapy in Patients With High Risk
ClinicalTrials.gov study NCT00256360. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Metronomic Oral Chemotherapy With Cyclophosphamide, Capecitabine and Vinorelbine in Metastatic Breast Cancer Patients
ClinicalTrials.gov study NCT04304352. IPD Sharing: NO. Countries: 1. Publications: 0.
Busulfan and Cyclophosphamide Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00004896. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Testing the Investigational Agent Combination of Daratumumab, Bortezomib, and Dexamethasone Compared to the Usual Treatment of Cyclophosphamide, Bortezomib, and Dexamethasone in Newly Diagnosed Multip
ClinicalTrials.gov study NCT07085728. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
Reduced Dose of Cyclophosphamide Combined With Standard Immunosuppressive Therapy to Treat Severe Aplastic Anemia
ClinicalTrials.gov study NCT06695741. IPD Sharing: NO. Countries: 1. Publications: 0.
Exploration of Genotype Based Personalized Prescription of Cyclophosphamide in Systemic Lupus Erythematosus Treatment
ClinicalTrials.gov study NCT01060410. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study in Letrozole Combined With Metronomic Oral Cyclophosphamide in Elderly Metastasis Breast Cancer Patients
ClinicalTrials.gov study NCT02583828. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Vaccine Therapy and Cyclophosphamide in Treating Patients With Stage II-III Breast or Stage II-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
ClinicalTrials.gov study NCT01606241. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy Study of GL-0817 (With Cyclophosphamide) for the Prevention of Recurrence of Squamous Cell Carcinoma of the Oral Cavity
ClinicalTrials.gov study NCT02873819. IPD Sharing: NO. Countries: 7. Publications: 0.
Therapeutic Autologous Lymphocytes, Cyclophosphamide, and Aldesleukin in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov study NCT01106235. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Autologous CD8+ SLC45A2-Specific T Lymphocytes With Cyclophosphamide, Aldesleukin, and Ipilimumab in Treating Patients With Metastatic Uveal Melanoma
ClinicalTrials.gov study NCT03068624. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pharmacokinetic Study of Tesmilifene (YMB1002) Plus Epirubicin and Cyclophosphamide in Metastatic Breast Cancer
ClinicalTrials.gov study NCT00364754. IPD Sharing: Not stated. Countries: 3. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.